(Circulation. 1996;93:1976-1980.)
© 1996 American Heart Association, Inc.
Articles |
From the Behavioral Medicine Research Center, Duke University Medical Center, Durham, NC; the Institute of Preventive Medicine, Copenhagen (Denmark) Municipal Hospital (J.B.); and Glostrup Population Studies, Copenhagen County Hospital (M.S.), Glostrup, Denmark.
| Abstract |
|---|
|
|
|---|
Methods and Results Study participants were 409 men and 321 women who were residents of Glostrup, Denmark, born in 1914. Physical and psychological examinations in 1964 and 1974 established their baseline risk factor and disease status and their level of depressive symptomatology. Initial myocardial infarction (MI) was observed in 122 participants, and there were 290 deaths during follow-up, which ended in 1991. A 2-SD difference in depression score was associated with relative risks of 1.71 (P=.005) for MI and 1.59 (P<.001) for deaths from all causes. These findings were unchanged after we controlled for risk factors and signs of disease at baseline. There were no sex differences in effect sizes.
Conclusions High levels of depressive symptomatology are associated with increased risks of MI and mortality. The graded relationships between depression scores and risk, long-lasting nature of the effect, and stability of the depression measured across time suggest that this risk factor is best viewed as a continuous variable that represents a chronic psychological characteristic rather than a discrete and episodic psychiatric condition.
Key Words: depression epidemiology mortality myocardial infarction risk factors
| Introduction |
|---|
|
|
|---|
Because coronary events often lead to heightened depression,5 cross-sectional designs are not desirable for the study of this question; prospective studies are necessary. The relevance of prospective studies of psychiatric samples6 for the general population is limited. Few longitudinal studies of depression and coronary disease have been conducted in nonclinical samples, and many of them have yielded no evidence of an association7 8 or have been inconclusive.9 However, a recent follow-up of a large national sample observed an elevated risk of ischemic heart disease among those individuals with high scores on measures of depressed affect and hopelessness.10
The present study addresses this issue by evaluating the ability of a measure of depressive symptoms from the MMPI11 to predict AMI over a 27-year period in a community sample of aging Danish men and women. Total mortality also was considered an outcome because some evidence suggests that depression is associated with increases in all-cause mortality.9 12 Baseline physical examinations provided information to be used as control for risk factors and initial disease status.
| Methods |
|---|
|
|
|---|
The 1964 examinations were performed on 436 men and 366 women. The physical examination involved a full day of testing at Glostrup Hospital. A detailed description of the procedures is available elsewhere.14 The psychological examination, including the MMPI, was conducted on the second day of testing. Some participants did not return for the psychological examination, so 1964 MMPI measures were gathered from 384 men and 289 women.
In 1974, the 890 surviving members of the target population were invited to participate in a second round of examinations. Physical examinations were administered to 666 participants, including 39 who were not included in the 1964 examinations. MMPI data were obtained from 570 participants in 1974, including 57 who did not take part in the 1964 psychological examination. For these participants, 1974 was considered to be the baseline, and exposure was computed from that point. Because this group was older at the time of their entry into the study, age at baseline was covaried in the analyses.
The sample of the present study is made up of the 409 men and 321 women for whom psychological measures were available from at least one examination. Comparisons were performed between the members of this sample and the 111 people who did not take the MMPI in either examination but participated in the other parts of the study. Those who did not take the MMPI were more likely to be female and to be among the 39 people with physical data from 1974 who did not participate in the 1964 examination. The two groups differed on only one other baseline variable considered in the study: those who did not take the MMPI had poorer pulmonary function at baseline. Cox proportional hazards models showed that those with no MMPI data did not differ from those with MMPI data in the incidences of AMI or death during the follow-up period after we accounted for the effects of age at baseline, sex, and pulmonary function.
Measurement of Depressive Symptoms
The most commonly used measure of depression on the MMPI is the
D scale, which has its origin in work with psychiatric samples. Items
on the D scale are heterogeneous, and many of them are not
face-valid reflections of depression.15 However, the
scale has been divided on the basis of face validity into obvious and
subtle subscales.16 The 40-item OBD subscale is a more
straightforward measure of depressive symptoms as experienced outside
the psychiatric context. It was therefore chosen as the measure for the
present study to increase the relevance of the findings for
nonpsychiatric populations. The 10-year test-retest correlation for
the OBD scale was .67 in those 513 individuals who took the test at
both the 1964 and 1974 examinations. Analyses with the complete
D scale also were performed but are not reported because they led to
the same conclusions as the OBD analyses.
As in most depression scales, some of the items on OBD pertain to somatic complaints (eg, "I feel weak all over much of the time"). Studies of depression and physical health must consider the possibility that such complaints might have an organic basis such as subclinical coronary disease rather than psychological origins. If so, relations between depression scores and disease outcomes might be spuriously inflated. Therefore, a second depression score was calculated with omission of the nine somatic items (MMPI items 9, 18, 23, 36, 51, 153, 154, 189, and 285) on OBD, and analyses were repeated to see whether the results with the full scale were due solely to the reports of somatic symptoms.
Baseline Risk Indicators
Blood Pressure
Blood pressure was measured with an arm cuff, Korotkoff phases I
and V, while the participant was supine after 10 minutes of rest. Only
the systolic reading was used in the analyses.
Blood Chemistry
Blood samples were drawn at the beginning of the examination
(8:15 AM) after a 13-hour fast that included abstinence
from smoking. These samples yielded measures of total serum
cholesterol, triglycerides, and insulin.
Smoking
Smoking was measured with a five-level variable:
nonsmoker, ex-smoker, and smoker of 1 to 14, 15 to 24, or 25 g/d or
more of tobacco. This index was coded into four dichotomous
variables for the analyses.
Physical Activity
There were two physical activity measures, physical activity at
work and amount of activity in leisure. Both were four-level
ordinal measures (sedentary, moderately active, active, and heavy work
or competitive sport) that were coded into three dichotomous
variables for analyses.
Body Mass
Body mass index was calculated as weight in kilograms divided by
height in meters squared.
Signs of Disease
Possible Ischemia
The possible existence of myocardial ischemia at
baseline was assessed in two ways, the Rose
questionnaire17 to test for symptoms of angina pectoris
and ECG. ECGs were taken after 10 minutes of rest and defined as
positive according to the Whitehall criteria as Minnesota codes 1.1 to
2.18 A dichotomous index combining these two measures was
created that was positive if either of the two assessment methods
suggested the presence of ischemia.
Pulmonary Function
A second important indicator of disease in this age group is
pulmonary function. It was evaluated with a Godart bell
respirator and a Wright peak flowmeter. Forced expiratory volume
(liters) in the first second (FEV1) was taken
as the indicator. Participants had one practice and two test trials,
with the highest value used in the analysis.
End Points
Follow-up of the participants has been aided by Danish
national registries for deaths, hospitalizations, and changes of
address. Additional data collection in 1984 and 1989 (not discussed in
this article) also helped ensure the completeness of the follow-up.
Except for four participants who emigrated, follow-up is complete
up to the end of this study, December 1991.
AMI
The incidence of fatal AMI was determined from death
certificates and supporting evidence from hospital records or
autopsy. The occurrences of nonfatal AMI were detected from hospital
records, with the diagnosis confirmed on two of three criteria:
typical pains, characteristic ECG changes, and changes in enzyme
levels.
AMI occurred in 91 men and 31 women during the course of follow-up. Five men and one woman were excluded from all analyses of this end point because they suffered nonfatal AMI before the 1964 examination, and 3 participants were excluded because they were lost to follow-up for this outcome.
Mortality
At the end of 1991, 196 men and 94 women, 40% of those with
MMPI data, were deceased. Causes of death were determined from death
certificates, autopsies, and hospital records. Death certificates
from the National Board of Health were coded by the Danish Institute
for Clinical Epidemiology. Ischemic
heart disease and MI (ICD codes 410 through 414) accounted for 88
deaths. Other cardiovascular diseases (ICD codes 390
through 409 and 415 through 458) were cited as the cause of 38 deaths.
Malignant neoplasms (ICD codes 140 through 239) were implicated as the
primary cause of death for 90 people. Only 10 of the deaths appear to
have been accidents or suicides. Cause of death has yet to be
determined for 22 people.
Analysis Strategy
The associations of OBD scores to each outcome were evaluated
with Cox proportional hazard survival models. OBD scores were treated
as continuous variables. Effect sizes are reported as RRs that were
calculated by exponentiating the ß from the model after it was
multiplied by the number of points equivalent to 2 SDs of the scale
(10.78 for the full OBD scale). Thus, the RR can be interpreted as the
risk of a person 1 SD above the mean compared with the risk of a person
1 SD below the mean. As stated above, the analyses also were
performed with the full D scale of the MMPI, but results did not differ
from those reported here.
Previous multivariate analyses based on the total Glostrup sample have established those risk indicators that are independent predictors of the primary end points, AMI and mortality.19 Risk factor controls in the present study were based on those analyses. Only those baseline risk factors that were significant in final versions of those models were included as covariates. By limiting the covariates to those that are independent predictors, problems of multicollinearity are minimized.
Four models were fitted to assess the ability of OBD scores to predict the AMI outcome. These analyses omitted the data of the 6 individuals who had an AMI before 1964 and 3 individuals lost to follow-up. The first model (n=721) contained controls for age and sex. The second model contained additional controls for risk factors shown to be independently related to the outcome19 : age, sex, systolic blood pressure, triglycerides, smoking, sedentary work, and sedentary leisure. There were 675 individuals in the second model owing to missing values on some of the covariables. The final two models were fitted to reduce the possibility that the prospective results were contaminated by the presence of prevalent cases at baseline. The third model (n=679) repeated the first model but eliminated the data of those participants who had signs of possible myocardial ischemia at baseline as evidenced by ECG or questionnaire. The fourth model was based on the same reduced sample but used an abbreviated version of the OBD scale that did not contain the nine items reflective of somatic complaints. Potential sex differences in effect sizes were evaluated by tests for interactions between OBD scores and sex. Potential deviations from linearity were evaluated with quadratic and cubic terms.
A similar set of models was performed for the mortality outcome. The first (n=730) controlled for age and sex only. The second (n=671) added controls for those risk factors found to be independently predictive of mortality (systolic blood pressure, triglycerides, and smoking) and pulmonary function, an important disease indicator. The third (n=682) eliminated the data of those individuals with possible ischemia or prior AMI at baseline. The fourth model repeated the same analysis with the abbreviated OBD scale that did not contain somatic items. Finally, separate models were fitted to predict deaths from ischemic heart disease and deaths from all other causes.
| Results |
|---|
|
|
|---|
|
Table 2
shows the partial correlations of OBD scores
with baseline risk variables by sex, controlling for age at
baseline. Among women, depressive symptoms were positively associated
with amount smoked and negatively associated with body mass index and
systolic blood pressure. These relationships were absent in
men, and the sex-by-OBD interactions were significant
(P
.02) for all three variables.
|
Cross-sectional analyses also evaluated the association of
OBD scores to signs of disease at baseline. Those participants who
reported more depressive symptoms were more likely to be among those to
show evidence of possible ischemia on the ECG or the Rose
questionnaire than those who described fewer symptoms. A logistic model
controlling for sex showed that the odds of a person having signs of
ischemia were 1.9 times greater for a person 1 SD above the OBD
mean than for a person 1 SD below the mean (
2 1
df=4.3; P<.05). Those participants with more
symptoms of depression also had poorer pulmonary function after
we controlled for other correlates of FEV1:
sex, age, systolic blood pressure, and smoking. The partial
correlation between OBD scores and FEV1 was
-.09 (P<.02).
Depressive Symptoms and AMI Incidence
Higher OBD scores were associated with increased risk of AMI in
all models (see Table 3
). Controls for
risk factors and elimination of those with possible ischemia
had virtually no impact on the size of the OBD effect. Removal of the
items dealing with somatic complaints reduced the effect size somewhat,
but it remained significant. Tests for an OBD-by-sex interaction
were not significant, indicating the absence of sex differences. The
Figure
illustrates a gradation of risk across the range
of OBD scores in both sexes.
|
|
Depressive Symptoms and Total Mortality
Reports of depressive symptoms were positively associated with the
risk of mortality from all causes (see Table 4
). The
effect was significant in all models. As in the AMI analyses,
there were no sex differences in effect size, and tests for departures
from linearity were not significant.
|
Further analyses divided deaths into two categories: those
attributed to ischemic heart disease and those due to all other
causes. Models fitted on the full sample showed that OBD scores
predicted both ischemic heart disease mortality (RR=1.62;
2 1 df=4.7; P=.03) and
mortality from all other causes (RR=1.57;
2 1
df=9.6; P=.002). Therefore, it does not appear
that the deleterious effects of depression on health are limited to
ischemic heart disease.
| Discussion |
|---|
|
|
|---|
Some research has shown that depression predicts total mortality12 and the prognosis of patients after MI,1 2 but evidence concerning the role of depression in the pathogenesis of coronary disease has been less clear. Several theoretical and methodological issues have contributed to the difficulty in establishing this relationship. One problem that has complicated research in this area is the influence of personality on the perception of symptoms. Because those individuals with depression and related psychological characteristics are more likely to report chest pain in the absence of coronary artery disease, they are more likely to be falsely diagnosed with angina pectoris.21 22 Therefore, it is important for studies to rely on "hard" outcomes such as documented AMI.
Another factor that has complicated research in this area is the similarity between the symptoms of depression and the symptoms of coronary disease. Because both illnesses result in tiredness, feelings of weakness, etc, it is possible that manifestations of subclinical heart disease could be mistaken for depressive symptomatology. Therefore, the apparent relation between depressive symptoms and coronary events could be spuriously inflated. There are several ways to address this problem. One is to exclude from analysis all coronary events that occur soon after baseline measurement on the assumption that subclinical coronary disease will become evident within the first few years. This strategy was adopted by Anda et al.10 In the present study, no coronary events occurred in the first year after baseline, and only 4 of the 122 infarctions occurred in the first 5 years, supporting the independence of the OBD measure from subclinical disease. A second solution is to eliminate somatic symptoms from consideration when depression is assessed. The present study found that the relationship was not dependent on the presence of somatic symptoms in the criteria for depression. A third approach is to include only those individuals who were symptom-free at baseline in the analyses. In the present study, the OBD effect was unchanged when those participants with symptomatic or ECG evidence of ischemia were eliminated from consideration.
The timing of events during the course of follow-up is also important because it helps distinguish the influence of depression from that of vital exhaustion, a related phenomenon that precedes MI.23 The risk associated with vital exhaustion is highest in the first few months after assessment and decreases over time.24 Because the short-term risk in the present study was low, it appears that OBD scores reflect depressive symptoms rather than vital exhaustion.
It is important to note that a graded increase of risk was observed across the distribution OBD scores. Anda et al10 observed a similar relationship. These findings, coupled with the fact that both studies were performed on representative samples of the normal population, suggest that it is appropriate to view this risk factor as a continuum of depressive symptoms rather than a psychiatric disorder of major depression. Signs of depression can show stability over time.25 This can be seen in the high correlation (.67) between OBD scores in the 1964 and 1974 Glostrup examinations. Such stability probably is necessary for depression to exert the type of chronic influence necessary for the development of coronary artery disease.
One way that depression affect might act to foster coronary disease and early mortality is through health habits such as smoking. Smoking was positively correlated with depressed affect among the women in the Glostrup sample, and Anda et al26 have observed positive associations between depressed affect and smoking in both men and women in a large national sample of the United States. However, OBD scores continued to predict both coronary events and total mortality after we controlled for a variety of risk factors (including smoking) and signs of disease at baseline. Some other mechanism, eg, heightened sympathetic reactivity, must be responsible for the association.
It has been suggested that depression might play an especially important role in the health of women.3 4 We found that OBD scores were equally predictive in men and women. However, the higher prevalence of depression in women20 could still mean that depressed affect is more significant for them.
Evidence from this and other studies is emerging to demonstrate the adverse health consequences of chronic depression. It is time to search for ways to ameliorate its effects.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
| Footnotes |
|---|
Received July 5, 1995; revision received September 29, 1995; accepted October 6, 1995.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
G. Brevetti, G. Giugliano, G. Oliva, S. Lanero, J.I. De Maio, and M. Chiariello The impact of comorbidity burden on the cardiovascular risk in the Peripheral Arteriopathy and Cardiovascular Events study QJM, July 1, 2008; 101(7): 575 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Thomas, D. W. Chapa, E. Friedmann, C. Durden, A. Ross, M. C. Y. Lee, and H.-J. Lee Depression in Patients With Heart Failure: Prevalence, Pathophysiological Mechanisms, and Treatment Crit. Care Nurse, April 1, 2008; 28(2): 40 - 55. [Full Text] [PDF] |
||||
![]() |
L. S. Kinder, K. A. Bradley, W. J. Katon, E. Ludman, M. B. McDonell, and C. L. Bryson Depression, Posttraumatic Stress Disorder, and Mortality Psychosom Med, January 1, 2008; 70(1): 20 - 26. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pieper, J. F. Brosschot, R. van der Leeden, and J. F. Thayer Cardiac Effects of Momentary Assessed Worry Episodes and Stressful Events Psychosom Med, November 1, 2007; 69(9): 901 - 909. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Fraguas Jr., D. V. Iosifescu, J. Alpert, S. R. Wisniewski, J. L. Barkin, M. H. Trivedi, A J. Rush, and M. Fava Major Depressive Disorder and Comorbid Cardiac Disease: Is There a Depressive Subtype With Greater Cardiovascular Morbidity? Results From the STAR*D Study Psychosomatics, October 1, 2007; 48(5): 418 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Boyle, R. S. Surwit, A. Georgiades, B. H. Brummett, M. J. Helms, R. B. Williams, and J. C. Barefoot Depressive Symptoms, Race, and Glucose Concentrations: The role of cortisol as mediator Diabetes Care, October 1, 2007; 30(10): 2484 - 2488. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Lanas, A. Avezum, L. E. Bautista, R. Diaz, M. Luna, S. Islam, S. Yusuf, and for the INTERHEART Investigators in Latin America Risk Factors for Acute Myocardial Infarction in Latin America: The INTERHEART Latin American Study Circulation, March 6, 2007; 115(9): 1067 - 1074. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. N. Jacka, J. A. Pasco, S. McConnell, L. J. Williams, M. A. Kotowicz, G. C. Nicholson, and M. Berk Self-Reported Depression and Cardiovascular Risk Factors in a Community Sample of Women Psychosomatics, February 1, 2007; 48(1): 54 - 59. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Stecker, J. C. Fortney, D. E. Steffick, and S. Prajapati The Triple Threat for Chronic Disease: Obesity, Race, and Depression Psychosomatics, December 1, 2006; 47(6): 513 - 518. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Kirby, V. P. Williams, M. C. Hocking, J. D. Lane, and R. B. Williams Psychosocial Benefits of Three Formats of a Standardized Behavioral Stress Management Program Psychosom Med, November 1, 2006; 68(6): 816 - 823. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Ziembroski and M. J. Breiding The Cumulative Effect of Rural and Regional Residence on the Health of Older Adults. J Aging Health, October 1, 2006; 18(5): 631 - 659. [Abstract] [PDF] |
||||
![]() |
P. Mansky, T. Sannes, D. Wallerstedt, A. Ge, M. Ryan, L. L. Johnson, M. Chesney, and L. Gerber Tai chi chuan: mind-body practice or exercise intervention? Studying the benefit for cancer survivors. Integr Cancer Ther, September 1, 2006; 5(3): 192 - 201. [Abstract] [PDF] |
||||
![]() |
L. L. Watkins, J. A. Blumenthal, J. R. T. Davidson, M. A. Babyak, C. B. McCants Jr, and M. H. Sketch Jr Phobic anxiety, depression, and risk of ventricular arrhythmias in patients with coronary heart disease. Psychosom Med, September 1, 2006; 68(5): 651 - 656. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. McCaffery, N. Frasure-Smith, M.-P. Dube, P. Theroux, G. A. Rouleau, Q. Duan, and F. Lesperance Common genetic vulnerability to depressive symptoms and coronary artery disease: a review and development of candidate genes related to inflammation and serotonin. Psychosom Med, March 1, 2006; 68(2): 187 - 200. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Empana, X. Jouven, R. N. Lemaitre, N. Sotoodehnia, T. Rea, T. E. Raghunathan, G. Simon, and D. S. Siscovick Clinical Depression and Risk of Out-of-Hospital Cardiac Arrest Arch Intern Med, January 23, 2006; 166(2): 195 - 200. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Thurston, L. D. Kubzansky, I. Kawachi, and L. F. Berkman Do Depression and Anxiety Mediate the Link Between Educational Attainment and CHD? Psychosom Med, January 1, 2006; 68(1): 25 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bunde and R. Martin Depression and Prehospital Delay in the Context of Myocardial Infarction Psychosom Med, January 1, 2006; 68(1): 51 - 57. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Gallo, H. R. Bogner, K. H. Morales, E. P. Post, T. Ten Have, and M. L. Bruce Depression, Cardiovascular Disease, Diabetes, and Two-Year Mortality Among Older, Primary-Care Patients Am J Geriatr Psychiatry, September 1, 2005; 13(9): 748 - 755. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nicholson, R. Fuhrer, and M. Marmot Psychological Distress as a Predictor of CHD Events in Men: The Effect of Persistence and Components of Risk Psychosom Med, July 1, 2005; 67(4): 522 - 530. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Elovainio, L. Keltikangas-Jarvinen, M. Kivimaki, L. Pulkki, S. Puttonen, T. Heponiemi, M. Juonala, J. S. A. Viikari, and O. T. Raitakari Depressive Symptoms and Carotid Artery Intima-Media Thickness in Young Adults: The Cardiovascular Risk in Young Finns Study Psychosom Med, July 1, 2005; 67(4): 561 - 567. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Grissom and R. A. Phillips Screening for Depression: This Is the Heart of the Matter Arch Intern Med, June 13, 2005; 165(11): 1214 - 1215. [Full Text] [PDF] |
||||
![]() |
J.P. Empana, D.H. Sykes, G. Luc, I. Juhan-Vague, D. Arveiler, J. Ferrieres, P. Amouyel, A. Bingham, M. Montaye, J.B. Ruidavets, et al. Contributions of Depressive Mood and Circulating Inflammatory Markers to Coronary Heart Disease in Healthy European Men: The Prospective Epidemiological Study of Myocardial Infarction (PRIME) Circulation, May 10, 2005; 111(18): 2299 - 2305. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Skarupski, C. F. Mendes de Leon, J. L. Bienias, L. L. Barnes, S. A. Everson-Rose, R. S. Wilson, and D. A. Evans Black-White Differences in Depressive Symptoms Among Older Adults Over Time J. Gerontol. B. Psychol. Sci. Soc. Sci., May 1, 2005; 60(3): P136 - P142. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Brown, S. R. Majumdar, S. C. Newman, and J. A. Johnson History of Depression Increases Risk of Type 2 Diabetes in Younger Adults Diabetes Care, May 1, 2005; 28(5): 1063 - 1067. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Frasure-Smith and F. Lesperance Reflections on Depression as a Cardiac Risk Factor Psychosom Med, May 1, 2005; 67(Supplement_1): S19 - S25. [Abstract] [Full Text] [PDF] |
||||
![]() |
B Wolff, H J Grabe, H Volzke, J Ludemann, C Kessler, J B Dahm, H J Freyberger, U John, and S B Felix Relation between psychological strain and carotid atherosclerosis in a general population Heart, April 1, 2005; 91(4): 460 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
L J Tata, J West, C Smith, P Farrington, T Card, L Smeeth, and R Hubbard General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction Heart, April 1, 2005; 91(4): 465 - 471. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Rasul, S A Stansfeld, C L Hart, and G Davey Smith Psychological distress, physical illness, and risk of coronary heart disease J. Epidemiol. Community Health, February 1, 2005; 59(2): 140 - 145. [Abstract] [Full Text] [PDF] |
||||
![]() |
S U Shah, A White, S White, and W A Littler Heart and mind: (1) relationship between cardiovascular and psychiatric conditions Postgrad. Med. J., December 1, 2004; 80(950): 683 - 689. [Abstract] [Full Text] [PDF] |
||||
![]() |
Depression Obstet. Gynecol., October 1, 2004; 104(4_suppl): 49S - 55S. [Full Text] [PDF] |
||||
![]() |